Decreased diabetes risk over 9 year after 18-month oral l-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of l-arginine study)

PURPOSE: This study aimed to determine whether l-arginine supplementation lasting for 18 months maintained long-lasting effects on diabetes incidence, insulin secretion and sensitivity, oxidative stress, and endothelial function during 108 months among subjects at high risk of developing type 2 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Monti, Lucilla D., Galluccio, Elena, Villa, Valentina, Fontana, Barbara, Spadoni, Serena, Piatti, Pier Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267392/
https://www.ncbi.nlm.nih.gov/pubmed/29052766
http://dx.doi.org/10.1007/s00394-017-1548-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267392/
https://www.ncbi.nlm.nih.gov/pubmed/29052766
http://dx.doi.org/10.1007/s00394-017-1548-2

Ejemplares similares